Risk of Vaccine-Induced Thrombotic Thrombocytopenia (VITT) following the AstraZeneca/COVISHIELD Adenovirus Vector COVID‑19 Vaccines Product: — Science Table Disease Mechanism Infectious Diseases & Clinical Care Vaccine Vaccines & Immunity covid19-sciencetable.ca Last Updated: May 11, 2021
Rapid COVID‑19 Testing Deployment And Non-Essential Business Sectors Product: — Evidence Synthesis Network Business Re-opening Rapid Testing Re-Opening Testing & Tracing esnetwork.ca Last Updated: March 18, 2021
Clinical Practice Guideline Summary: Recommended Drugs and Biologics in Adult Patients with COVID-19 Product: — Science Table Drug Interventions Infectious Diseases & Clinical Care Treatments covid19-sciencetable.ca Last Updated: February 25, 2021
COVID-19 Outcomes For Priority Populations And Settings Product: — Evidence Synthesis Network Health Inequities Low SES Vulnerable Groups Vulnerable Sub-populations esnetwork.ca Last Updated: February 22, 2021
Transmission Risk Factors, and Mitigation of COVID‑19 When Re-Opening Playground Equipment Product: — Evidence Synthesis Network Business Re-opening Re-Opening Recreation Recreation Grounds esnetwork.ca Last Updated: May 28, 2020
COVID-19: Opening Community Gardens Safely Product: — Institut national de santé publique du Québec Business Re-opening Re-Opening Recreation Recreation Grounds www.inspq.qc.ca Last Updated: May 22, 2020 Also available in Français
International Lessons Learned from Re-opening Non-COVID-19 Activities in Hospitals Product: — Evidence Synthesis Network Healthcare Re-opening Hospital Infection Control Infection Control Guidelines Re-Opening esnetwork.ca Last Updated: May 13, 2020